Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

FDA approves first human trials of Myeliviz for PET imaging in MS

Jan. 29, 2020

AC Immune patents alpha-synuclein-targeting compounds for PET imaging

Dec. 31, 2019

PET imaging agent PyL meets primary endpoint in phase III prostate cancer trial

Dec. 24, 2019

New adenosine A2A receptor antagonists identified at Evotec, Ex Scientia

Dec. 20, 2019

[18F]GTP-1 imaging shown to be useful to detect cognitive decline

Dec. 17, 2019

89Zr-DFO-MSTP-2109A shows promise as companion diagnostic in patients with mCRPC

Dec. 4, 2019

First-in-human study of 89Zr-DFO-REGN-3504 for imaging PD-L1 tumors

Nov. 29, 2019

APRINOIA Therapeutics describes compounds targeting microtubule-associated protein tau

Nov. 26, 2019

Aprinoia begins phase II study of tau PET tracer 18F-APN-1607

Nov. 22, 2019

Cerveau Technologies starts Japanese phase I study of [18F]MK-6240

Nov. 15, 2019

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...